Evaluation of Muc1 Gene Expression at The Time of Implantation in Diabetic Rat Models Treated with Insulin, Metformin and Pioglitazone in The Normal Cycle and Ovulation Induction Cycle

Background: Mucin-1(Muc1) is one of the first molecules in the endometrium that confronts implanting embryos.There is insufficient knowledge about the impacts of diabetes and drugs developed for diabetes treatment on expressionof this molecule at the time of implantation. Therefore, this study aimed...

Full description

Bibliographic Details
Main Authors: Ronak Zarei, Parvaneh Nikpour, Bahman Rashidi, Nahid Eskandari, Roshanak Aboutorabi
Format: Article
Language:English
Published: Royan Institute (ACECR), Tehran 2020-10-01
Series:International Journal of Fertility and Sterility
Subjects:
Online Access:http://www.ijfs.ir/article_46216_3058251121dd6fc6944976fea65fd45b.pdf
_version_ 1818554936323997696
author Ronak Zarei
Parvaneh Nikpour
Bahman Rashidi
Nahid Eskandari
Roshanak Aboutorabi
author_facet Ronak Zarei
Parvaneh Nikpour
Bahman Rashidi
Nahid Eskandari
Roshanak Aboutorabi
author_sort Ronak Zarei
collection DOAJ
description Background: Mucin-1(Muc1) is one of the first molecules in the endometrium that confronts implanting embryos.There is insufficient knowledge about the impacts of diabetes and drugs developed for diabetes treatment on expressionof this molecule at the time of implantation. Therefore, this study aimed to investigate the impacts of diabetes andinsulin, metformin and pioglitazone on Muc1 expression at the time of implantation.Materials and Methods: This experimental study was conducted on a total of 63 female Wistar rats divided into 9groups. To induce type 1diabetes, streptozotocin (STZ) and for induction of type 2 diabetes, nicotinamide (NA) andSTZ were injected intraperitoneally. For superovulation, human menopausal gonadotropin (HMG) and human chorionicgonadotropin (HCG) were used. Insulin, metformin and pioglitazone were administered for two weeks. Finally,the endometrial expression of Muc1 was evaluated by quantitative real-time reverse transcription–polymerase chainreaction (RT-PCR).Results: Muc1 expression was non-significantly increased in type 1 and type 2 diabetic groups compared to the controlgroup (P=0.61 and 0.13, respectively); also, it increased in insulin-treated type 1 diabetic group compared to thecontrol group (P=0.0001). Its expression was increased in insulin-treated type 1 diabetic group compared to untreateddiabetic group (P=0.001). The expression level of Muc1 was significantly reduced in superovulated and insulin-treatedtype 1 diabetic group compared to the insulin-treated type 1 diabetic group (P=0.001).Conclusion: One of the causes of fertility problems in diabetes, is changes in Muc1 expression during implantation.On the other hand, the use of insulin in these patients can even lead to overexpression of this gene and worsen thecondition. However, these changes can be partially mitigated by assisted reproductive technology (ART) such as superovulation.Also, treatment with metformin and pioglitazone can restore Muc1 expression to near normal levels andhas beneficial effects on implantation
first_indexed 2024-12-12T09:46:36Z
format Article
id doaj.art-5312208dc72442d8a87acf645a4476c4
institution Directory Open Access Journal
issn 2008-076X
2008-0778
language English
last_indexed 2024-12-12T09:46:36Z
publishDate 2020-10-01
publisher Royan Institute (ACECR), Tehran
record_format Article
series International Journal of Fertility and Sterility
spelling doaj.art-5312208dc72442d8a87acf645a4476c42022-12-22T00:28:23ZengRoyan Institute (ACECR), TehranInternational Journal of Fertility and Sterility2008-076X2008-07782020-10-0114321822210.22074/ijfs.2020.4440946216Evaluation of Muc1 Gene Expression at The Time of Implantation in Diabetic Rat Models Treated with Insulin, Metformin and Pioglitazone in The Normal Cycle and Ovulation Induction CycleRonak Zarei0Parvaneh Nikpour1Bahman Rashidi2Nahid Eskandari3Roshanak Aboutorabi4Department of Anatomical Sciences, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Genetics and Molecular Biology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Anatomical Sciences, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IranBackground: Mucin-1(Muc1) is one of the first molecules in the endometrium that confronts implanting embryos.There is insufficient knowledge about the impacts of diabetes and drugs developed for diabetes treatment on expressionof this molecule at the time of implantation. Therefore, this study aimed to investigate the impacts of diabetes andinsulin, metformin and pioglitazone on Muc1 expression at the time of implantation.Materials and Methods: This experimental study was conducted on a total of 63 female Wistar rats divided into 9groups. To induce type 1diabetes, streptozotocin (STZ) and for induction of type 2 diabetes, nicotinamide (NA) andSTZ were injected intraperitoneally. For superovulation, human menopausal gonadotropin (HMG) and human chorionicgonadotropin (HCG) were used. Insulin, metformin and pioglitazone were administered for two weeks. Finally,the endometrial expression of Muc1 was evaluated by quantitative real-time reverse transcription–polymerase chainreaction (RT-PCR).Results: Muc1 expression was non-significantly increased in type 1 and type 2 diabetic groups compared to the controlgroup (P=0.61 and 0.13, respectively); also, it increased in insulin-treated type 1 diabetic group compared to thecontrol group (P=0.0001). Its expression was increased in insulin-treated type 1 diabetic group compared to untreateddiabetic group (P=0.001). The expression level of Muc1 was significantly reduced in superovulated and insulin-treatedtype 1 diabetic group compared to the insulin-treated type 1 diabetic group (P=0.001).Conclusion: One of the causes of fertility problems in diabetes, is changes in Muc1 expression during implantation.On the other hand, the use of insulin in these patients can even lead to overexpression of this gene and worsen thecondition. However, these changes can be partially mitigated by assisted reproductive technology (ART) such as superovulation.Also, treatment with metformin and pioglitazone can restore Muc1 expression to near normal levels andhas beneficial effects on implantationhttp://www.ijfs.ir/article_46216_3058251121dd6fc6944976fea65fd45b.pdfdiabetes mellitusembryo implantationmuc1ovulation induction
spellingShingle Ronak Zarei
Parvaneh Nikpour
Bahman Rashidi
Nahid Eskandari
Roshanak Aboutorabi
Evaluation of Muc1 Gene Expression at The Time of Implantation in Diabetic Rat Models Treated with Insulin, Metformin and Pioglitazone in The Normal Cycle and Ovulation Induction Cycle
International Journal of Fertility and Sterility
diabetes mellitus
embryo implantation
muc1
ovulation induction
title Evaluation of Muc1 Gene Expression at The Time of Implantation in Diabetic Rat Models Treated with Insulin, Metformin and Pioglitazone in The Normal Cycle and Ovulation Induction Cycle
title_full Evaluation of Muc1 Gene Expression at The Time of Implantation in Diabetic Rat Models Treated with Insulin, Metformin and Pioglitazone in The Normal Cycle and Ovulation Induction Cycle
title_fullStr Evaluation of Muc1 Gene Expression at The Time of Implantation in Diabetic Rat Models Treated with Insulin, Metformin and Pioglitazone in The Normal Cycle and Ovulation Induction Cycle
title_full_unstemmed Evaluation of Muc1 Gene Expression at The Time of Implantation in Diabetic Rat Models Treated with Insulin, Metformin and Pioglitazone in The Normal Cycle and Ovulation Induction Cycle
title_short Evaluation of Muc1 Gene Expression at The Time of Implantation in Diabetic Rat Models Treated with Insulin, Metformin and Pioglitazone in The Normal Cycle and Ovulation Induction Cycle
title_sort evaluation of muc1 gene expression at the time of implantation in diabetic rat models treated with insulin metformin and pioglitazone in the normal cycle and ovulation induction cycle
topic diabetes mellitus
embryo implantation
muc1
ovulation induction
url http://www.ijfs.ir/article_46216_3058251121dd6fc6944976fea65fd45b.pdf
work_keys_str_mv AT ronakzarei evaluationofmuc1geneexpressionatthetimeofimplantationindiabeticratmodelstreatedwithinsulinmetforminandpioglitazoneinthenormalcycleandovulationinductioncycle
AT parvanehnikpour evaluationofmuc1geneexpressionatthetimeofimplantationindiabeticratmodelstreatedwithinsulinmetforminandpioglitazoneinthenormalcycleandovulationinductioncycle
AT bahmanrashidi evaluationofmuc1geneexpressionatthetimeofimplantationindiabeticratmodelstreatedwithinsulinmetforminandpioglitazoneinthenormalcycleandovulationinductioncycle
AT nahideskandari evaluationofmuc1geneexpressionatthetimeofimplantationindiabeticratmodelstreatedwithinsulinmetforminandpioglitazoneinthenormalcycleandovulationinductioncycle
AT roshanakaboutorabi evaluationofmuc1geneexpressionatthetimeofimplantationindiabeticratmodelstreatedwithinsulinmetforminandpioglitazoneinthenormalcycleandovulationinductioncycle